S 3677119th CongressIn Committee
Dietary Supplement Listing Act of 2026
Standard Summary
Balanced plain-English summary
This bill requires manufacturers, packers, or distributors of dietary supplements marketed in the United States to list their products and specified label information with the FDA, creates a public searchable database, and imposes misbranding consequences for noncompliance.
Key Points
- 1Requires responsible persons to submit dietary supplement listings to FDA
- 2Creates a public electronic database while keeping certain business and proprietary blend information confidential
- 3Sets deadlines for existing products, new products, discontinued products, and label changes
- 4Treats failure to comply as misbranding and adds a prohibited act related to debarred persons
- 5Authorizes appropriations for FDA implementation
Impact Areas
Dietary supplement manufacturers and distributorsFDAConsumersRetailersForeign supplement companies and U.S. agents
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026